• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小分子介导的活细胞内 RNA 切割。

Small-molecule-mediated cleavage of RNA in living cells.

机构信息

Department of Chemistry, The Scripps Research Institute, Scripps Florida, 130 Scripps Way, 3A1, Jupiter, FL 33458, USA.

出版信息

Angew Chem Int Ed Engl. 2013 Jan 28;52(5):1462-5. doi: 10.1002/anie.201206888. Epub 2012 Dec 20.

DOI:10.1002/anie.201206888
PMID:23280953
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3711026/
Abstract

Antisense oligonucleotides and small interfering RNAs (siRNAs) control gene expression by triggering the degradation of a mRNA via recruitment of RNase H or the RNA-induced silencing complex (RISC), respectively. These approaches are hampered, however, by the poor cellular permeability of oligonucleotides. A small molecule approach to cleave RNA targets could obviate uptake issues. Several compounds can induce RNA cleavage , however, to the best of our knowledge no small molecules have been previously described to cleave RNA in living cells. Herein, we describe the development of a potentially general approach to design small molecules that specifically cleave an RNA in a living cell, affecting biological function. Specifically, a designed, modularly assembled small molecule that binds the RNA that causes myotonic dystrophy type 1 (DM1) was appended with a moiety that generates hydroxyl radicals upon irradiation. Cleavage of the transcript improves DM1-associated defects in cell culture, and compounds are non-toxic at an efficacious dose as determined by a MTT viability assay. This approach may allow for the site-specific cleavage and inactivation of other cellular RNAs. Compounds that bind to and cleave RNA have the potential to serve as chemical genetics probes of function or lead therapeutics with spatial and temporal control.

摘要

反义寡核苷酸和小干扰 RNA(siRNA)通过分别招募核糖核酸酶 H 或 RNA 诱导沉默复合物(RISC)来触发 mRNA 的降解,从而控制基因表达。然而,这些方法受到寡核苷酸细胞通透性差的阻碍。一种切割 RNA 靶标的小分子方法可以避免摄取问题。有几种化合物可以诱导 RNA 切割,但是据我们所知,以前没有描述过小分子可以在活细胞中切割 RNA 以影响生物功能。在此,我们描述了一种设计专门在活细胞中切割特定 RNA 的小分子的潜在通用方法,从而影响生物功能。具体而言,设计了一种模块化组装的小分子,该小分子与导致 1 型肌强直性营养不良(DM1)的 RNA 结合,并附加了一个在照射时产生羟基自由基的部分。该转录物的切割改善了细胞培养中与 DM1 相关的缺陷,并且通过 MTT 活力测定确定,在有效剂量下化合物没有毒性。这种方法可能允许对其他细胞 RNA 进行特异性切割和失活。与 RNA 结合并切割 RNA 的化合物具有作为化学遗传学功能探针或具有时空控制的治疗剂的潜力。

相似文献

1
Small-molecule-mediated cleavage of RNA in living cells.小分子介导的活细胞内 RNA 切割。
Angew Chem Int Ed Engl. 2013 Jan 28;52(5):1462-5. doi: 10.1002/anie.201206888. Epub 2012 Dec 20.
2
NMR spectroscopy and molecular dynamics simulation of r(CCGCUGCGG)₂ reveal a dynamic UU internal loop found in myotonic dystrophy type 1.NMR 光谱和分子动力学模拟 r(CCGCUGCGG)₂ 揭示了肌强直性营养不良 1 型中发现的动态 UU 内环。
Biochemistry. 2011 Feb 8;50(5):599-601. doi: 10.1021/bi101896j. Epub 2011 Jan 13.
3
Molecular biology. Neutralizing toxic RNA.分子生物学。中和有毒RNA。
Science. 2009 Jul 17;325(5938):272-3. doi: 10.1126/science.1177452.
4
Does (CUG)n repeat in DMPK mRNA 'paint' chromosome 19 to suppress distant genes to create the diverse phenotype of myotonic dystrophy?: A new hypothesis of long-range cis autosomal inactivation.DMPK mRNA中的(CUG)n重复序列是否会“描绘”19号染色体以抑制远处基因从而产生强直性肌营养不良的多样表型?:一种常染色体远距离顺式失活的新假说。
Neurogenetics. 2001 Mar;3(2):59-67. doi: 10.1007/s100480000103.
5
The structural basis of myotonic dystrophy from the crystal structure of CUG repeats.来自CUG重复序列晶体结构的强直性肌营养不良的结构基础。
Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16626-31. doi: 10.1073/pnas.0505873102. Epub 2005 Nov 3.
6
CUG repeats present in myotonin kinase RNA form metastable "slippery" hairpins.肌强直性营养不良蛋白激酶RNA中存在的CUG重复序列形成亚稳态的“滑动”发夹结构。
J Biol Chem. 1997 Dec 5;272(49):31079-85. doi: 10.1074/jbc.272.49.31079.
7
Is myotonic dystrophy a single-gene disorder?强直性肌营养不良是单基因疾病吗?
Biochem Soc Trans. 1996 May;24(2):510-3. doi: 10.1042/bst0240510.
8
Getting a grip on the myotonic dystrophies.了解强直性肌营养不良症
Neurology. 1999 Jan 1;52(1):12-3. doi: 10.1212/wnl.52.1.12.
9
Distribution of CTG repeats at the DMPK gene in myotonic dystrophy patients and healthy individuals from the Mexican population.DMPK 基因 CTG 重复在肌强直性营养不良患者和墨西哥人群中健康个体的分布。
Mol Biol Rep. 2011 Feb;38(2):1341-6. doi: 10.1007/s11033-010-0235-7. Epub 2010 Jul 16.
10
Myotonic dystrophy--a multigene disorder.强直性肌营养不良——一种多基因疾病。
Brain Res Bull. 2001;56(3-4):389-95. doi: 10.1016/s0361-9230(01)00656-6.

引用本文的文献

1
The Druggable Transcriptome Project: From Chemical Probes to Precision Medicines.可药物作用转录组计划:从化学探针到精准药物
Biochemistry. 2025 Apr 15;64(8):1647-1661. doi: 10.1021/acs.biochem.5c00006. Epub 2025 Mar 25.
2
A Toxic RNA Templates the Synthesis of Its Own Fluorogenic Inhibitor by Using a Bio-orthogonal Tetrazine Ligation in Cells and Tissues.一种毒性 RNA 通过细胞和组织中生物正交的四嗪连接反应,利用其自身的荧光抑制剂模板来合成其自身的荧光抑制剂。
ACS Chem Biol. 2020 Jul 17;15(7):1820-1825. doi: 10.1021/acschembio.0c00417. Epub 2020 Jun 17.
3
Precise Targeted Cleavage of a r(CUG) Repeat Expansion in Cells by Using a Small-Molecule-Deglycobleomycin Conjugate.利用小分子去糖博来霉素缀合物在细胞中精确靶向切割 r(CUG) 重复扩展。
ACS Chem Biol. 2020 Apr 17;15(4):849-855. doi: 10.1021/acschembio.0c00036. Epub 2020 Mar 18.
4
Identifying and validating small molecules interacting with RNA (SMIRNAs).识别和验证与RNA相互作用的小分子(SMIRNAs)。
Methods Enzymol. 2019;623:45-66. doi: 10.1016/bs.mie.2019.04.027. Epub 2019 May 15.
5
Understanding the Contributions of Conformational Changes, Thermodynamics, and Kinetics of RNA-Small Molecule Interactions.理解 RNA-小分子相互作用的构象变化、热力学和动力学的贡献。
ACS Chem Biol. 2019 May 17;14(5):824-838. doi: 10.1021/acschembio.8b00945. Epub 2019 May 1.
6
Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model.精准切割肌强直性营养不良小鼠模型中的 r(CUG)重复扩展的小分子。
Proc Natl Acad Sci U S A. 2019 Apr 16;116(16):7799-7804. doi: 10.1073/pnas.1901484116. Epub 2019 Mar 29.
7
Precise Small Molecule Degradation of a Noncoding RNA Identifies Cellular Binding Sites and Modulates an Oncogenic Phenotype.精确的小分子降解非编码 RNA 可鉴定细胞结合位点并调节致癌表型。
ACS Chem Biol. 2018 Nov 16;13(11):3065-3071. doi: 10.1021/acschembio.8b00827. Epub 2018 Oct 30.
8
Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms.呋咱甲氢龙通过多种机制挽救肌强直性营养不良 1 型相关的剪接错误。
ACS Chem Biol. 2018 Sep 21;13(9):2708-2718. doi: 10.1021/acschembio.8b00646. Epub 2018 Aug 27.
9
Using Genome Sequence to Enable the Design of Medicines and Chemical Probes.利用基因组序列来设计药物和化学探针。
Chem Rev. 2018 Feb 28;118(4):1599-1663. doi: 10.1021/acs.chemrev.7b00504. Epub 2018 Jan 11.
10
Small molecule alteration of RNA sequence in cells and animals.细胞和动物中RNA序列的小分子改变。
Bioorg Med Chem Lett. 2018 Sep 1;28(16):2794-2796. doi: 10.1016/j.bmcl.2017.10.034. Epub 2017 Oct 18.

本文引用的文献

1
RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1.肌强直性营养不良 1 型中 RNase H 介导的毒性 RNA 降解。
Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4221-6. doi: 10.1073/pnas.1117019109. Epub 2012 Feb 27.
2
Rationally designed small molecules targeting the RNA that causes myotonic dystrophy type 1 are potently bioactive.针对导致 1 型肌强直性营养不良的 RNA 进行合理设计的小分子具有很强的生物活性。
ACS Chem Biol. 2012 May 18;7(5):856-62. doi: 10.1021/cb200408a. Epub 2012 Mar 5.
3
Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching.通过 RNA 基序-配体数据库和化学相似性搜索设计靶向肌强直性营养不良 1 型 RNA 的生物活性小分子。
J Am Chem Soc. 2012 Mar 14;134(10):4731-42. doi: 10.1021/ja210088v. Epub 2012 Mar 5.
4
Recent advances in developing small molecules targeting RNA.靶向 RNA 的小分子的最新进展。
ACS Chem Biol. 2012 Jan 20;7(1):73-86. doi: 10.1021/cb200447r. Epub 2012 Jan 12.
5
Myotonic dystrophy type 1 RNA crystal structures reveal heterogeneous 1 × 1 nucleotide UU internal loop conformations.肌强直性营养不良 1 型 RNA 晶体结构揭示了异质的 1×1 核苷酸 UU 内部环构象。
Biochemistry. 2011 Nov 15;50(45):9928-35. doi: 10.1021/bi2013068. Epub 2011 Oct 20.
6
In vivo discovery of a peptide that prevents CUG-RNA hairpin formation and reverses RNA toxicity in myotonic dystrophy models.体内发现一种可防止 CUG-RNA 发夹形成并逆转肌强直性营养不良模型中 RNA 毒性的肽。
Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):11866-71. doi: 10.1073/pnas.1018213108. Epub 2011 Jul 5.
7
Cleavage of RNA phosphodiester bonds by small molecular entities: a mechanistic insight.小分子物质对 RNA 磷酸二酯键的切割:一种机制上的见解。
Org Biomol Chem. 2011 Mar 21;9(6):1687-703. doi: 10.1039/c0ob00486c. Epub 2011 Jan 24.
8
Structure-activity relationships through sequencing (StARTS) defines optimal and suboptimal RNA motif targets for small molecules.通过测序的构效关系(StARTS)确定了小分子的最佳和次优RNA基序靶点。
Angew Chem Int Ed Engl. 2010 May 17;49(22):3816-8. doi: 10.1002/anie.200907257.
9
Pentamidine reverses the splicing defects associated with myotonic dystrophy.喷他脒可逆转与强直性肌营养不良相关的剪接缺陷。
Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18551-6. doi: 10.1073/pnas.0903234106. Epub 2009 Oct 12.
10
Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy.三联体重复寡核苷酸介导的强直性肌营养不良症中RNA毒性的逆转
Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13915-20. doi: 10.1073/pnas.0905780106. Epub 2009 Aug 10.